Clinical Trial Update: Emicizumab PUPs and Nuwiq ITI Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing emicizumab PUPs and Nuwiq ITI has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Emicizumab (emicizumab)
• Nuwiq (recombinant factor VIII concentrate)

Snippet

Sponsor: Emory University | Conditions: Hemophilia A | Phase 3 | Status: WITHDRAWN